(BPT) – Do you live with persistent, moderate-to-severe asthma, COPD, allergies, eczema or hives? Inflammation is often a major factor in the severity of your symptoms. It could also be a factor if ...

Panelists discuss how identifying type 2 inflammation in patients influences treatment decisions by steering clinicians toward targeted therapies, such as biologics or other immunomodulators, that ...

Reynold A. Panettieri Jr., MD, examines the application of biologic therapies in the treatment of respiratory conditions. Biologics are currently available for asthma management and being studied in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The phase 3 BOREAS trial included adults with ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Asthma and cardiovascular diseases (CVDs) are intricately linked, because of their widespread prevalence ...

Anti-inflammatory foods support gut and heart health and may lower cancer risk in men over 50. Men over 50 should add foods ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Bhatt’s study, "Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts,” was recently published in The New England Journal of Medicine. Bhatt and colleagues conducted a multicenter ...

Meteorin-like protein (Metrnl) is an emerging secreted factor with a multifaceted role in regulating metabolism and modulating inflammatory responses. Initially identified as an adipomyokine, Metrnl ...

Two weeks of an intensive diabetes treatment has shown promise in improving periodontal disease inflammation among patients with type 2 diabetes. The corresponding study was published in Diabetes, ...